Inventor · disambiguated record
Richard Sackler
Also filed as: SACKLER RICHARD · SACKLER RICHARD S
48 granted patents·22 pending applications·4,918 citations·filing 1982–2018
99Inventor score
Files withPURDUE PHARMA LP27EURO CELTIQUE SA20BURCH RONALD M6SACKLER RICHARD S4RHODES PHARMACEUTICALS LP3
Top patents by PatentIndex Score
70 records- 0199US8017148B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agentPURDUE PHARMA LP·Filed 2006·Granted Sep 13, 2011·96 cites·20 claims
- 0299US7727557B2Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2006·Granted Jun 1, 2010·91 cites·24 claims
- 0399US7332182B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritantPURDUE PHARMA LP·Filed 2002·Granted Feb 19, 2008·289 cites·20 claims
- 0499US7157103B2Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2002·Granted Jan 2, 2007·246 cites·43 claims
- 0599US5672360AMethod of treating pain by administering 24 hour oral opioid formulationsPURDUE PHARMA LP·Filed 1994·Granted Sep 30, 1997·492 cites·14 claims
- 0699US5478577AMethod of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelEURO CELTIQUE SA·Filed 1993·Granted Dec 26, 1995·470 cites·10 claims
- 0798US8652515B2Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agentSACKLER RICHARD·Filed 2011·Granted Feb 18, 2014·68 cites·21 claims
- 0898US8652497B2Pharmaceutical formulation containing irritantSACKLER RICHARD·Filed 2010·Granted Feb 18, 2014·88 cites·20 claims
- 0998US6921541B2Formulations and methods for providing prolonged local anesthesiaEURO CELTIQUE SA·Filed 2002·Granted Jul 26, 2005·183 cites·24 claims
- 1098US6524607B1Formulations and methods for providing prolonged local anesthesiaEURO CELTIQUE SA·Filed 2000·Granted Feb 25, 2003·262 cites·1 claims
- 1198US6143322AMethod of treating humans with opioid formulations having extended controlled releasePURDUE PHARMA LP·Filed 1997·Granted Nov 7, 2000·326 cites·13 claims
- 1298US5942241AFormulations and methods for providing prolonged local anesthesiaEURO CELTIQUE SA·Filed 1996·Granted Aug 24, 1999·346 cites·41 claims
- 1398US5747060AProlonged local anesthesia with colchicineEURO CELTIQUE SA·Filed 1996·Granted May 5, 1998·346 cites·33 claims
- 1498US5716611AEmollient antimicrobial formulations containing povidone iodineEURO CELTIQUE SA·Filed 1996·Granted Feb 10, 1998·155 cites·19 claims
- 1597US7790215B2Sustained-release gel coated compositionsPURDUE PHARMA LP·Filed 2003·Granted Sep 7, 2010·89 cites·77 claims
- 1697US6552031B1Synergistic analgesic combination of oxycodone and rofecoxibEURO CELTIQUE SA·Filed 1998·Granted Apr 22, 2003·126 cites·19 claims
- 1797US6534081B2Prolonged anesthesia in joints and body spacesEURO CELTIQUE SA·Filed 2001·Granted Mar 18, 2003·221 cites·31 claims
- 1897US6248345B1Prolonged anesthesia in joints and body spacesEURO CELTIQUE SA·Filed 1998·Granted Jun 19, 2001·284 cites·38 claims
- 1996US7125561B2Compartmentalized dosage formEURO CELTIQUE SA·Filed 2002·Granted Oct 24, 2006·55 cites·2 claims
- 2095US9155717B2Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2014·Granted Oct 13, 2015·8 cites·36 claims
- 2195US6699908B2Methods for providing safe local anesthesiaEURO CELTIQUE SA·Filed 2001·Granted Mar 2, 2004·91 cites·27 claims
- 2295US6521259B1Formulations and methods for providing prolonged local anesthesiaEURO CELTIQUE SA·Filed 2000·Granted Feb 18, 2003·69 cites·3 claims
- 2394US7083808B2Controlled/modified release oral methylphenidate formulationsEURO CELTIQUE SA·Filed 2003·Granted Aug 1, 2006·84 cites·10 claims
- 2492US9233073B2Tamper resistant solid oral dosage formsSACKLER RICHARD S·Filed 2011·Granted Jan 12, 2016·17 cites·45 claims
- 2592US8143267B2Analgesic combination of oxycodone and nimesulideBURCH RONALD M·Filed 2002·Granted Mar 27, 2012·32 cites·24 claims
- 2691US8193209B2Analgesic combination of oxycodone and meloxicamBURCH RONALD M·Filed 2002·Granted Jun 5, 2012·27 cites·20 claims
- 2791US8097278B2Compartmentalized dosage formSACKLER RICHARD S·Filed 2006·Granted Jan 17, 2012·8 cites·2 claims
- 2891US6514516B1Formulations and methods for providing prolonged local anesthesiaEURO CELTIQUE SA·Filed 1999·Granted Feb 4, 2003·70 cites·5 claims
- 2991US6017963AFormulation for intranasal administrationEURO CELTIQUE SA·Filed 1995·Granted Jan 25, 2000·89 cites·11 claims
- 3090US6673367B1Controlled/modified release oral methylphenidate formulationsEURO CELTIQUE SA·Filed 1999·Granted Jan 6, 2004·102 cites·5 claims
- 3187US9326954B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agentPURDUE PHARMA LP·Filed 2013·Granted May 3, 2016·2 cites·20 claims
- 3283US8685994B2Analgesic combination of oxycodone and celecoxibBURCH RONALD M·Filed 2007·Granted Apr 1, 2014·3 cites·11 claims
- 3382US6642275B2Formulation for respiratory tract administrationEURO CELTIQUE SA·Filed 2001·Granted Nov 4, 2003·14 cites·12 claims
- 3481US9707180B2Methods of preparing tamper resistant solid oral dosage formsPURDUE PHARMA LP·Filed 2016·Granted Jul 18, 2017·2 cites·18 claims
- 3580US9370512B2Buprenorphine-wafer for drug substitution therapyPURDUE PHARMA LP·Filed 2015·Granted Jun 21, 2016·2 cites·24 claims
- 3680US8168629B2Analgesic combination of tramadol and meloxicamBURCH RONALD M·Filed 2007·Granted May 1, 2012·2 cites·13 claims
- 3780US4954351AMethod of producing standardized povidone iodine preparations and such preparationsEURO CELTIQUE SA·Filed 1988·Granted Sep 4, 1990·38 cites·9 claims
- 3878US9101625B2Buprenorphine-wafer for drug substitution therapyOKSCHE ALEXANDER·Filed 2007·Granted Aug 11, 2015·3 cites·14 claims
- 3978US7740881B1Method of treating humans with opioid formulations having extended controlled releasePURDUE PHARMA LP·Filed 2000·Granted Jun 22, 2010·7 cites·23 claims
- 4075US2019046522A1Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 4174US2008031963A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2007·Application pending·0 cites
- 4274US2007237833A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2007·Application pending·0 cites
- 4372US10022369B2Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2017·Granted Jul 17, 2018·0 cites·25 claims
- 4472US2006269604A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2006·Application pending·0 cites
- 4571US2010209351A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelSACKLER RICHARD S·Filed 2009·Application pending·0 cites
- 4671US2010209514A1Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug levelSACKLER RICHARD S·Filed 2009·Application pending·0 cites
- 4769US2017119756A1Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 4868US9511065B2Pharmaceutical formulation containing irritantPURDUE PHARMA LP·Filed 2015·Granted Dec 6, 2016·0 cites·14 claims
- 4966US8188107B2Analgesic combination of oxycodone and N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl] methanesulfonamideBURCH RONALD M·Filed 2002·Granted May 29, 2012·1 cites·35 claims
- 5066US2007237832A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2007·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard Sackler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →